Critical Care Nutrition Market Overview: 2030:
The global critical care nutrition market size was valued at $10,618.96 million in 2020, and is projected to reach $19,237.81 million by 2030, registering a CAGR of 6.3% from 2021 to 2030.
Critical care nutrition offers the nutrition support therapy for critically ill patients to gain positive patient outcomes. Critical care is the provision for safer and appropriate nutrition, which needs to be provided to patients admitted in the ICU that requires evidence-based practice. The critical care nutritional therapy is approved to patients suffering from chronic illness such as gastrointestinal disorder and cancer. In addition, the nutrition therapy, if taken in early stages, may assist in decreasing the disease severity and reduce complications that are caused due to insufficiency of nutrition. Furthermore, decrease in length of stay in the ICU and decline in the rate of mortality in patient population, who have undergone early nutritional therapy are expected to support the market to generate higher revenue during the forecast period.
Surge in healthcare spending is likely to help the market gain traction during the forecast period. Moreover, increase in prevalence of chronic disorders such as cancer and neurological disorders is the major factor that contributes toward the growth of the global critical care nutrition market. According to the statistics given by the American Society of Clinical Oncology Journal in 2020, incidence rate of cancer was higher among females, which was about 712,758 than males, which was about 679,421 for the year 2020. The projected national cancer incidence burden in 2020 will be 98.7 per 100,000 population that is approximately 1,392,179 patients as a conservative estimate.
In addition, increase in geriatric population is expected to fuel the market growth. This is attributed to the fact aged individuals are highly susceptible to suffer from critical illness. According to the statistics given by the United Nations in 2020, the world ageing population is about 727 million who are aged 65 years and above across the globe, and is estimated to reach 1.5 billion by 2050. However, lack of awareness regarding critical care nutrition for patients admitted in the ICU in underdeveloped countries hinders the market growth.
On the contrary, the development of newer technologically advanced products and high market potential in untapped emerging economies are projected to provide lucrative opportunities for the growth of the critical care nutrition market.
By Route Of Administration
The Enteral instruments segment is expected to lead the market throughout the forecast period.
The World Health Organization (WHO) on January 30, 2021 declared COVID-19 outbreak a public health emergency of international concern. The critical care nutrition can be used for assistance in various critical illnesses. Decreased hospital stays due to early nutrition therapy would help the market grow with the advent of COVID-19 during the forecast period. In addition, fulfillment of nutritional deficiencies through critical care nutrition is anticipated to help the market generate higher revenue during the forecast period.
By Application
The Neurological Diseases segment is expected to lead the market throughout the forecast period.
Critical Care Nutrition Market Segmentation
The global critical care nutrition market is segmented into route of administration, application, age group, and region. On the basis of route of administration, the market is bifurcated into enteral and parenteral. The applications covered in the study include cancer, neurological diseases, gastrointestinal disorders, and others. Depending on age group, the market is segregated into pediatric, adults, geriatric. The pediatric segment is further divided into enteral and parenteral nutrition. Furthermore, the adults segment is categorized into enteral and parenteral. The geriatric segment is further fragmented into enteral and parenteral nutrition. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Region
Asia Pacific segment held a fastest CAGR in 2020, furthermoreNorth America is expected to register the highest revenue share during the forecast period.
Segment review
On the basis of route of administration, the enteral segment dominated the global critical care nutrition market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to advantages posed by the enteral route of administration, including improvement in gastrointestinal tract’s (GI) blood flow and improvement in GI mucosal health. In addition, minimal side effects caused due to enteral route of administration as compared to other mode of administration will help the segment generate higher revenue in the coming years.
Depending on application, the cancer segment dominated the global critical care nutrition market in 2020, and is anticipated to continue this trend in the future. This is attributable to surge in adoption of sedentary lifestyle leading to increase in prevalence of cancer.
On the basis of end user, the geriatric segment garnered majority of the share, owing to increase in number of patients suffering from chronic diseases such as diabetes, cancer, and gastrointestinal disorders. Furthermore, surge in geriatric population that requires critical care nutrition is expected to contribute to the critical care nutrition market growth.
List Of Key Companies
- Abbott Laboratories
- Fresenius Kabi AG
- Danone S.A.
- Mead Johnson & Company LLC
- Baxter International Inc.
- B.Braun Melsungen AG
- Nestle S.A.
- Meiji Holdings Co., Ltd.
- Reckitt Benckiser Group PLC.
- Victus, Inc.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the critical care nutrition market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- The report covers the market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the critical care nutrition market.
- A comprehensive analysis of factors that drive and restrain the growth of the market is provided.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and critical care nutrition market growth.
Key Market Segments
By Route of Administration
- Enteral
- Parenteral
By Application
- Cancer
- Neurological Diseases
- Gastrointestinal Disorders
- Others
By End User
- Pediatric
- Enteral
- Parenteral
- Adults
- Enteral
- Parenteral
- Geriatric
- Enteral
- Parenteral
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Critical Care Nutrition Market Report Highlights
| Aspects | Details |
 By ROUTE OF ADMINISTRATION |
|
 By APPLICATION |
|
 By AGE GROUP |
|
 By Region |
|
 Key Market Players | B. BRAUN MELSUNGEN AG, BAXTER INTERNATIONAL, INC., NESTLE S.A., ABBOTT LABORATORIES, VICTUS INC., HORMEL FOODS CORPORATION, MEIJI HOLDINGS CO., LTD., FRESENIUS KABI AKTIENGESELLSCHAFT, RECKITT BENCKISER GROUP PLC, DANONE S.A. |
Analyst Review
Critical care nutrition is provision of safe and optimal nutrition that need to be provided to patients admitted to the ICU, using evidence based practice.
Increase in prevalence of conditions such as cancer, neurological diseases, and gastrointestinal diseases worldwide notbaly contributes toward the market growth. Furthermore, adoption of smoking, higher exposure to toxic materials, adverse climate conditions & air pollution, causing cancer will help the market gain traction during the forecast period. However, lack of awareness of critical care nutrition at early stages hinders the growth of the market.
North America is expected to remain dominant during the forecast period, owing to increase in demand for critical care nutrition, rise in incidence of cancer, and presence of major key players along with R&D centers in the region. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to key players during the forecast period, owing to increase in demand for critical care nutrition in the region along with higher adoption of sedentary lifestyle by the population.
Critical Care Nutrition is a therapy that is given for the indviduals suffering from critical illness and are admitted to intensive care units due to severity of the conidition.
Critical Care Nutrition are used when the healthcare professionals require assistance in providing nutritional therapy with required components to the patients admitted to intensive care units
The total value of Critical Care Nutrition market was $10,618.96 million in 2020.
The forecast period in the report is from 2021-2030.
The market value of Critical Care Nutrition market in 2030 was $19,237.81 million.
The base year calculated in the report is 2020.
Increased demand for the Critical Care Nutrition for decreasing the duration of stays in hospitals and rise in admissions to ICUs will drive the market over the near future according to the KOLs.
The market has drawn the interest of the healthcare industry, owing to increasing prevalence of cardiovascular diseases, rise in product launches of Critical Care Nutrition, and growing awareness among healthcare professionals regarding Critical Care Nutrition
By route of administration, the enteral segment holds the maximum market share.
The market in Asia-Pacific is expected to register lucrative CAGR of 7.4% over the forecast period owing to presence of large population base, increase in awareness regarding Critical Care Nutrition, and rise in disposable income
Loading Table Of Content...
